These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [What is the present status of the common virus vaccines?]. Regnard J Nouv Presse Med; 1972 Jan; 1(1):33-8. PubMed ID: 5061188 [No Abstract] [Full Text] [Related]
5. Benefits, risks and costs of viral vaccines. Koplan JP; Axnick NW Prog Med Virol; 1982; 28():180-91. PubMed ID: 6806868 [No Abstract] [Full Text] [Related]
12. RECENT DEVELOPMENTS IN BIOLOGICAL PRODUCTS. II. GERSHENFELD L Am J Pharm Sci Support Public Health; 1963 Oct; 135():360-79. PubMed ID: 14071361 [No Abstract] [Full Text] [Related]
14. [Use of diploid cell lines as a multiplication substrate for viral vaccine production]. Welke G Z Gesamte Hyg; 1980; 26(5):365-72. PubMed ID: 7008390 [No Abstract] [Full Text] [Related]
15. [Present issues in antiviral vaccines (author's tranls)]. Pauluzzi S Ann Sclavo; 1979; 21(6):823-35. PubMed ID: 554552 [TBL] [Abstract][Full Text] [Related]
16. Vaccine requirements of college students. Blake PA J Am Coll Health Assoc; 1972 Dec; 21(2):131-3. PubMed ID: 4641386 [No Abstract] [Full Text] [Related]
17. [Effects of viral vaccines and related problems]. Takahashi M; Okuno Y Saishin Igaku; 1968 Jun; 23(6):1195-206. PubMed ID: 4302901 [No Abstract] [Full Text] [Related]
18. New recommendations for simultaneous administration of live virus vaccines. Reeve AM J Iowa Med Soc; 1973 Feb; 63(2):50 passim. PubMed ID: 4687453 [No Abstract] [Full Text] [Related]
19. Approaches to the control of viral infections in man. Stevens DA; Merigan TC Ration Drug Ther; 1971 Sep; 5(9):1-5. PubMed ID: 5105931 [No Abstract] [Full Text] [Related]
20. Long-term follow-up for immunity after monovalent or combined live measles, mumps, and rubella virus vaccines. Weibel RE; Buynak EB; McLean AA; Hilleman MR Pediatrics; 1975 Sep; 56(3):380-7. PubMed ID: 1161394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]